Welcome to our dedicated page for Stryker news (Ticker: SYK), a resource for investors and traders seeking the latest updates and insights on Stryker stock.
Stryker Corporation reports developments as a global medical technology company serving MedSurg, Neurotechnology and Orthopaedics markets. Company news commonly covers operating results, organic sales trends, segment performance, dividends, shareholder-meeting activity and executive finance or investor-relations appointments.
Stryker updates also address portfolio expansion across medical devices, implants, instruments, operating-room equipment, neurotechnology and vascular solutions. Recent corporate activity includes the completed acquisition of Amplitude Vascular Systems, adding an intravascular lithotripsy platform for peripheral arterial disease to Stryker's peripheral vascular portfolio.
Stryker (NYSE:SYK) launched its Pangea Plating System in Europe for treating a wide range of fracture patterns. The first European clinical case was completed at St. George's University Hospital in London.
The system offers anatomically focused plates, streamlined instrumentation, and variable-angle plating for fracture fixation across upper and lower extremities, and was developed with input from 26 orthopaedic surgeons using global anatomical data.
Stryker (NYSE:SYK) agreed to acquire Amplitude Vascular Systems for up to $835 million, in a pre-FDA exit backed by BioStar Capital. The deal is described as a milestone in expanding Stryker’s peripheral vascular portfolio with AVS’s hydraulic intravascular lithotripsy technology for calcified peripheral arterial disease.
Stryker (NYSE:SYK) completed the acquisition of Amplitude Vascular Systems on May 7, 2026, adding a next‑generation intravascular lithotripsy (IVL) platform for complex peripheral arterial disease.
The deal brings AVS’s CO₂‑generated pressure wave technology into Stryker’s peripheral vascular portfolio, intended to expand treatment options for challenging arterial disease and support physicians and patient outcomes.
Stryker (NYSE:SYK) Board declared a quarterly dividend of $0.88 per share, payable July 31, 2026, to shareholders of record at close on June 30, 2026. The dividend represents a 4.8% increase year-over-year and is unchanged from the prior quarter.
Stryker (NYSE:SYK) will present at the Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13, 2026 at the Encore at Wynn Hotel in Las Vegas. The presentation by Spencer Stiles, Jason Beach and Nick Mead is scheduled for 1:40 p.m. PT.
A live webcast and replay will be available and archived on Stryker's Investor Relations website at www.stryker.com.
Stryker (NYSE:SYK) reported Q1 2026 net sales of $6.02 billion, up 2.6% year-over-year and organic net sales up 2.4%. Reported diluted EPS was $1.93 (+14.2%), while adjusted EPS was $2.60 (down 8.5%). Adjusted operating margin was 21.1%, a 180-basis-point contraction. Management said the company recovered from a cyber incident, completed an Ortho Tech reorganization, and maintained full-year guidance of organic growth 8.0%–9.5% and adjusted EPS $14.90–$15.10.
Stryker (NYSE:SYK) signed a definitive agreement on April 13, 2026 to acquire Amplitude Vascular Systems to add a next-generation intravascular lithotripsy (IVL) platform for treating calcified peripheral arterial disease.
The technology uses pulsed CO2-generated pressure waves via an IVL balloon catheter, aims to improve deliverability and treatment speed, and will complement Stryker's Peripheral Vascular portfolio once cleared for use. Transaction remains subject to customary closing conditions; both companies will operate separately until close.
Stryker (NYSE:SYK) will release financial results for its first quarter of fiscal 2026 on Thursday, April 30, 2026. A press release will be issued at approximately 4:05 p.m. ET with summary financial information for the quarter ended March 31, 2026.
The company will host a live webcast at 4:30 p.m. ET on April 30, 2026, with an archived replay available on the company website about two hours after the call ends.
Stryker (NYSE: SYK) appointed Nick Mead as Vice President, Investor Relations, effective May 1, 2026. Mead has nearly 20 years at Stryker with finance leadership across divisions, most recently as Vice President, Finance for the Medical division.
Jason Beach is named Vice President, Group Chief Financial Officer, MedSurg and Neurotechnology, reflecting internal promotions and continuity in finance and investor communications.
Stryker (NYSE:SYK) announced its 2026 Annual Meeting of Shareholders will be held Wednesday, May 6, 2026 at 12:00 p.m. Eastern Time. The meeting will be conducted virtually via the internet and the live webcast will include audio and the slide presentation.
A recording will be available beginning 10:30 a.m. ET on Thursday, May 7, 2026 at www.virtualshareholdermeeting.com/SYK2026 and will remain available until the company files its definitive proxy statement for the 2027 annual meeting.